MDR/RR-TB patients 18+ participate in cohort study at ~20 hospitals in Germany; Inclusion 2025–2027 for MDR/RR-TB adults

Where can patients participate in the MDR/RR-TB cohort study? - DZK

No1Lost – Together Against TB

Eligible patients are invited to participate in the cohort study by the treating study physicians at approximately 20 hospitals in Germany. Participation is voluntary and requires comprehensive information and written consent from the patients in their native language. Between 2025 and 2027, all individuals aged 18 or older with confirmed multidrug-resistant or rifampicin-resistant tuberculosis (MDR

RR-TB) may be included in the prospective study. A prerequisite is treatment for MDR

RR-TB within the study period at one of the participating study centers.

You can find more information about the studyhere.

As of April 27, 2026

Where can patients participate in the MDR

What social and medical resources are available to help ensure treatment adherence among people with tuberculosis?

What is the goal of the nationwide MDR

RR-TB cohort study conducted as part of No1Lost?

Can technical devices for video-supported therapy (VST) be provided as medical aids?

Who covers the costs of medical aids for uninsured tuberculosis patients?

Is the support provided by “No1Lost” free of charge?

+49 (0)30 81 49 09 22

Walterhöferstr. 11, Haus Q, 14165 Berlin

Stay up to date on the latest developments in the prevention and treatment of tuberculosis.